HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Henze, E. Articles by Phelps, M. E. Search for Related Content PubMed PubMed Citation Articles by Henze, E. Articles by Phelps, M. E.

Evaluation of Myocardial Metabolism, with N-13- and C-11-Labeled Amino Acids and Positron Computed Tomography

UCLA School of Medicine, University of California at Los Angeles, Los Angeles, California

Correspondence: For reprints contact: Eberhard Henze, MD, UCLA School of Medicine Div. of Nuclear Medicine, Los Angeles, CA 90024.

ABSTRACT

To evaluate the utility of labeled L-amino acids (AA) for imaging regional myocardial AA metabolism by positron computed tomography (PCT), the myocardial uptake and clearance of Ala,* Glu, Gln, Asp, Leu tagged with N-13, and of C-11-tagged Asp, and oxaloacetate (Oxal), were examined in 44 experiments at control, during ischemia, and after transaminase inhibition. The myocardial time-activity curves recorded after intracoronary tracer injection had two clearance phases (an early and a late) for all N-13 AA, and three (early, intermediate, late) for the two C-11 compounds, with significantly different clearance half-times of 18.7 ± 8.0 (s.d.) sec for the early phase, 141.7 ± 56.5 sec for the intermediate, and 61.2 ± 43.5 min for the late phase. The residual fractions ranged from 0.07 to 0.23 in normal myocardium, and consistently increased with ischemia by 0.02–0.07 for N-13-labeled Ala, Glu, Asp, and Leu, but not for N-13 Gln and the C-11 compounds. Transaminase inhibition shortened the half-time of the late phases on N-13-labeled Ala, Glu, Asp, and Leu; had no effect on t_1/2 of N-13 Gln and C-11 Oxal; and resulted in a loss of C-11 CO₂ production and of the intermediate phase for C-11 Asp. On the PCT images, N-13 activity from labeled Ala and Glu was not decreased in an ischemic segment despite a significant flow reduction, as demonstrated by N-13 NH₂ imaging and labeled microspheres. From the results, a three-compartment tracer kinetic model is proposed for the noninvasive quantification of Krebs-cycle activity, protein synthesis, and metabolic derangements related to ischemia.

This article has been cited by other articles:

				Z. Xiangsong, Y. Dianchao, and T. Anwu Dynamic 13N-Ammonia PET: A New Imaging Method to Diagnose Hypopituitarism J. Nucl. Med., January 1, 2005; 46(1): 44 - 47. [Abstract] [Full Text] [PDF]